Kala Bio KALA
NASDAQ KALA
$0.41 -0.02 (-4.40%)
As of: Oct 1, 2026 · 2:53 PM EDT

Kala Bio (KALA) Gross Margin (2019 - 2022)

Updated

Kala Bio's Gross Margin was 34.22% in FY2022, down 29.33 percentage points from 63.55% in FY2021.

Analysis

Kala Bio (KALA) Gross Margin (2019 - 2022) Analysis & Trends

From FY2019 onward, Kala Bio has reported Gross Margin for 4 years.

  • Gross Margin shows a three-year change of -32.72 percentage points (FY2019 to FY2022).
  • Per Business Quant data, Gross Margin in earlier years was 63.55% in FY2021 (+13.42 pp), 50.13% in FY2020 (-16.82 pp) and 66.94% in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 68.19%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 74.74%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 73.54%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 78.02%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 83.60%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 72.04%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 79.76%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 85.33%
10 Kala Bio 6.57 Mn 6.57 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 97.38%
Jun 30, 2022 15.52%
Mar 31, 2022 43.51%
Dec 31, 2021 23.60%
Sep 30, 2021 70.39%
Jun 30, 2021 66.70%
Mar 31, 2021 76.88%
Dec 31, 2020 39.28%
Sep 30, 2020 68.42%
Jun 30, 2020 8.88%
Mar 31, 2020 66.95%
Dec 31, 2019 36.69%
Sep 30, 2019 53.96%
Jun 30, 2019 82.89%
Mar 31, 2019 82.61%
API Access

Kala Bio Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=KALA&period=max&api_key=YOUR_API_KEY